TNYA Other | Tenaya Therapeutics, Inc.

Tenaya Therapeutics, Inc. Other

Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.

2026-05-06: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.0001 per share · TNYA · Nasdaq Global Select Market.
2026-03-11: Form 10-K; Item Stock registered under Section 12(b); As filed Common Stock $0.0001 par value per share · TNYA · Nasdaq Global Select Market.
2025-11-10: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.0001 per share · TNYA · Nasdaq Global Select Market.
2025-08-06: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, par value $0.0001 per share · TNYA · Nasdaq Global Select Market.

Filed	Form	Item	As filed
2026-05-06	10-Q	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · TNYA · Nasdaq Global Select Market
2026-03-11	10-K	Stock registered under Section 12(b)	Common Stock $0.0001 par value per share · TNYA · Nasdaq Global Select Market
2025-11-10	10-Q	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · TNYA · Nasdaq Global Select Market
2025-08-06	10-Q	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · TNYA · Nasdaq Global Select Market
2025-05-07	10-Q	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · TNYA · Nasdaq Global Select Market
2025-03-10	10-K	Stock registered under Section 12(b)	Common Stock $0.0001 par value per share · TNYA · Nasdaq Global Select Market
2024-11-06	10-Q	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · TNYA · Nasdaq Global Select Market
2024-08-08	10-Q	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · TNYA · Nasdaq Global Select Market
2024-05-14	10-Q	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · TNYA · Nasdaq Global Select Market
2024-03-18	10-K	Stock registered under Section 12(b)	Common Stock $0.0001 par value per share · TNYA · Nasdaq Global Select Market
2023-11-08	10-Q	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · TNYA · Nasdaq Global Select Market
2023-08-09	10-Q	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · TNYA · Nasdaq Global Select Market
2023-05-10	10-Q	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · TNYA · Nasdaq Global Select Market
2023-03-08	10-K	Stock registered under Section 12(b)	Common Stock $0.0001 par value per share · TNYA · Nasdaq Global Select Market
2022-11-10	10-Q	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · TNYA · Nasdaq Global Select Market
2022-08-10	10-Q	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · TNYA · Nasdaq Global Select Market
2022-05-11	10-Q	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · TNYA · Nasdaq Global Select Market
2022-03-23	10-K	Stock registered under Section 12(b)	Common Stock $0.0001 par value per share · TNYA · Nasdaq Global Select Market
2021-11-10	10-Q	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · TNYA · Nasdaq Global Select Market
2021-09-08	10-Q	Stock registered under Section 12(b)	Common Stock, par value $0.0001 per share · TNYA · Nasdaq Global Select Market
2021-09-08	10-Q	Current in its reporting	No

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Caribou Biosciences, Inc. (CRBU)	United States	$0.134B	-1.79
Armata Pharmaceuticals, Inc. (ARMP)	United States	$0.132B
Neumora Therapeutics, Inc. (NMRA)	United States	$0.132B	-1.48
enGene Therapeutics Inc. (ENGN)		$0.129B	-0.92
Humacyte, Inc. (HUMA)	United States	$0.155B	-2.26
Outlook Therapeutics, Inc. (OTLK)	United States	$0.162B	-4.90
Acumen Pharmaceuticals, Inc. (ABOS)	United States	$0.162B	-1.83
LENZ Therapeutics, Inc. (LENZ)	United States	$0.117B	-1.41
Black Diamond Therapeutics, Inc. (BDTX)	United States	$0.109B	-2.48
Voyager Therapeutics, Inc. (VYGR)	United States	$0.173B	-1.99